Healthwell Acquisition Corp. I
$10.48+$0.01 (+0.05%)
Healthwell Acquisition Corp. I’s quoted price sits in the lower half of its reported 52-week range, 11.86% below the high.
NASDAQ · FSRX · USD
Stock price, earnings
Quote as of Dec 7, 2023, 06:18 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
FinServ Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 10.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow FinServ Acquisition Corp. II’s reporting calendar.
THE COMPANY BEHIND THE TICKER
FinServ Acquisition Corp. II currently lacks substantial operational activities. The company's primary objective is to finalize a strategic business combination, which may take various forms such as a merger, an exchange of equity, the acquisition of assets or shares, or a corporate restructuring with one or more enterprises. Its strategic search is concentrated on identifying suitable target companies within the financial technology (FinTech) and broader financial services sectors. Established in 2020, the firm operates from its headquarters in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.48+$0.01 (+0.05%)
Healthwell Acquisition Corp. I’s quoted price sits in the lower half of its reported 52-week range, 11.86% below the high.
$9.82+$0.02 (+0.2%)
Viking Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 0.81% below the high.
$11.95+$11.95 (+100.0%)
Evergreen Corporation’s quoted price sits in the upper half of its reported 52-week range, 2.13% below the high.
$10.26+$0.01 (+0.1%)
Hawks Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 9.68% below the high.
$10.82+$10.82 (+100.0%)
Global Lights Acquisition Corp Ordinary Shares’s quoted price sits in the upper half of its reported 52-week range, 1.19% below the high.
$12.00$0.00 (0.0%)
Investcorp India Acquisition Corp’s quoted price sits in the upper half of its reported 52-week range, 2.99% below the high.
$10.65+$0.03 (+0.28%)
Osiris Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 12.13% below the high.
$10.68-$0.18 (-1.66%)
Disruptive Acquisition Corporation I’s quoted price sits in the lower half of its reported 52-week range, 19.09% below the high.